Literature DB >> 18755798

7-oxysterols modulate glucocorticoid activity in adipocytes through competition for 11beta-hydroxysteroid dehydrogenase type.

Malgorzata Wamil1, Ruth Andrew, Karen E Chapman, Jonathan Street, Nicholas M Morton, Jonathan R Seckl.   

Abstract

Obesity is associated with an increased risk of diabetes type 2, dyslipidemia, and atherosclerosis. These cardiovascular and metabolic abnormalities are exacerbated by excessive dietary fat, particularly cholesterol and its metabolites. High adipose tissue glucocorticoid levels, generated by the intracellular enzyme 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1), are also implicated in the pathogenesis of obesity, metabolic syndrome, and atherosclerosis. 11beta-HSD1 also interconverts the atherogenic oxysterols 7-ketocholesterol (7KC) and 7beta-hydroxycholesterol (7beta-HC). Here, we report that 11beta-HSD1 catalyzes the reduction of 7KC to 7beta-HC in mature 3T3-L1 and 3T3-F442A adipocytes, leading to cellular accumulation of 7beta-HC. Approximately 73% of added 7KC was reduced to 7beta-HC within 24 h; this conversion was prevented by selective inhibition of 11beta-HSD1. Oxysterol and glucocorticoid conversion by 11beta-HSD1 was competitive and occurred with a physiologically relevant IC(50) range of 450 nm for 7KC inhibition of glucocorticoid metabolism. Working as an inhibitor of 11beta-reductase activity, 7KC decreased the regeneration of active glucocorticoid and limited the process of differentiation of 3T3-L1 preadipocytes. 7KC and 7beta-HC did not activate liver X receptor in a transactivation assay, nor did they display intrinsic activation of the glucocorticoid receptor. However, when coincubated with glucocorticoid (10 nm), 7KC repressed, and 7beta-HC enhanced, glucocorticoid receptor transcriptional activity. The effect of 7-oxysterols resulted from the modulation of 11beta-HSD1 reaction direction, and could be ameliorated by overexpression of hexose 6-phosphate dehydrogenase, which supplies reduced nicotinamide adenine dinucleotide phosphate to 11beta-HSD1. Thus, the activity and reaction direction of adipose 11beta-HSD1 is altered under conditions of oxysterol excess, and could impact upon the pathophysiology of obesity and its complications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18755798     DOI: 10.1210/en.2008-0420

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  16 in total

1.  Alteration of some inflammatory biomarkers by dietary oxysterols in rats.

Authors:  Ida Soto-Rodríguez; Alfonso Alexander-Aguilera; Antonio Zamudio-Pérez; Mireya Camara-Contreras; Guillermo Hernandez-Diaz; Hugo S Garcia
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

2.  Guardian of corpulence: a hypothesis on p53 signaling in the fat cell.

Authors:  Merlijn Bazuine; Karin G Stenkula; Maggie Cam; Mathilde Arroyo; Samuel W Cushman
Journal:  Clin Lipidol       Date:  2009-04-01

3.  Modulation of retinoic acid receptor-related orphan receptor alpha and gamma activity by 7-oxygenated sterol ligands.

Authors:  Yongjun Wang; Naresh Kumar; Laura A Solt; Timothy I Richardson; Leah M Helvering; Christine Crumbley; Ruben D Garcia-Ordonez; Keith R Stayrook; Xi Zhang; Scott Novick; Michael J Chalmers; Patrick R Griffin; Thomas P Burris
Journal:  J Biol Chem       Date:  2009-12-04       Impact factor: 5.157

4.  A novel NADP(+)-dependent dehydrogenase activity for 7alpha/beta- and 11beta-hydroxysteroids in human liver nuclei: A third 11beta-hydroxysteroid dehydrogenase.

Authors:  B Robinzon; R A Prough
Journal:  Arch Biochem Biophys       Date:  2009-05-03       Impact factor: 4.013

5.  Hexose-6-phosphate dehydrogenase contributes to skeletal muscle homeostasis independent of 11β-hydroxysteroid dehydrogenase type 1.

Authors:  Nina M Semjonous; Mark Sherlock; Pancharatnam Jeyasuria; Keith L Parker; Elizabeth A Walker; Paul M Stewart; Gareth G Lavery
Journal:  Endocrinology       Date:  2010-11-24       Impact factor: 4.736

Review 6.  11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.

Authors:  Karen Chapman; Megan Holmes; Jonathan Seckl
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

Review 7.  11β-hydroxysteroid dehydrogenases: A growing multi-tasking family.

Authors:  Elise P Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Mol Cell Endocrinol       Date:  2021-02-17       Impact factor: 4.102

8.  OSBP-related proteins (ORPs) in human adipose depots and cultured adipocytes: evidence for impacts on the adipocyte phenotype.

Authors:  You Zhou; Marius R Robciuc; Martin Wabitsch; Anne Juuti; Marja Leivonen; Christian Ehnholm; Hannele Yki-Järvinen; Vesa M Olkkonen
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

9.  Mass spectrometry imaging for dissecting steroid intracrinology within target tissues.

Authors:  Diego F Cobice; C Logan Mackay; Richard J A Goodwin; Andrew McBride; Patrick R Langridge-Smith; Scott P Webster; Brian R Walker; Ruth Andrew
Journal:  Anal Chem       Date:  2013-11-19       Impact factor: 6.986

10.  11β-Hydroxysteroid dehydrogenase type 1 contributes to the regulation of 7-oxysterol levels in the arterial wall through the inter-conversion of 7-ketocholesterol and 7β-hydroxycholesterol.

Authors:  Tijana Mitić; Ruth Andrew; Brian R Walker; Patrick W F Hadoke
Journal:  Biochimie       Date:  2012-08-23       Impact factor: 4.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.